Cargando…

Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr(−/−) mice

BACKGROUND AND AIMS: Obesity, hepatosteatosis, and hypertriglyceridemia are components of the metabolic syndrome and independent risk factors for cardiovascular disease. The lipid droplet-associated protein CIDEC (cell death-inducing DFFA-like effector C), known in mice as FSP27 (fat-specific protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rajamoorthi, Ananthi, Lee, Richard G., Baldán, Ángel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113075/ https://www.ncbi.nlm.nih.gov/pubmed/29859472 http://dx.doi.org/10.1016/j.atherosclerosis.2018.05.045

Ejemplares similares

Amelioration of diet-induced steatohepatitis in mice following combined therapy with ASO-Fsp27 and fenofibrate
por: Rajamoorthi, Ananthi, et al.
Publicado: (2017)

Therapeutic silencing of fat-specific protein 27 improves glycemic control in mouse models of obesity and insulin resistance
por: Langhi, Cédric, et al.
Publicado: (2017)

T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice
por: Getz, Godfrey S., et al.
Publicado: (2018)

Macrophage deficiency of Akt2 reduces atherosclerosis in Ldlr null mice
por: Babaev, Vladimir R., et al.
Publicado: (2014)

Gene expression profile in the fat tissue of Fsp27 deficient mice
por: Xu, Li, et al.
Publicado: (2015)

Scavenging of reactive dicarbonyls with 2-hydroxybenzylamine reduces atherosclerosis in hypercholesterolemic Ldlr(−/−) mice
por: Tao, Huan, et al.
Publicado: (2020)

Lipid droplets fatten up with Fsp27
por: Short, Ben
Publicado: (2011)

Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice
por: Bisgaard, Line S., et al.
Publicado: (2016)

Pravastatin and Sarpogrelate Synergistically Ameliorate Atherosclerosis in LDLr-Knockout Mice
por: Park, Kyung-Yeon, et al.
Publicado: (2016)

Poloxamer 407 Induces Hypertriglyceridemia but Decreases Atherosclerosis in Ldlr(−/−) Mice
por: Peng, Xueying, et al.
Publicado: (2022)

Loss of Rictor in Monocyte/Macrophages Suppresses Their Proliferation and Viability Reducing Atherosclerosis in LDLR Null Mice
por: Babaev, Vladimir R., et al.
Publicado: (2018)

Tanshinone IIA alleviates atherosclerosis in LDLR(−/−) mice by regulating efferocytosis of macrophages
por: Wang, Jiarou, et al.
Publicado: (2023)

Regulation of gene expression by FSP27 in white and brown adipose tissue
por: Li, De, et al.
Publicado: (2010)

Insulin resistance and white adipose tissue inflammation are uncoupled in energetically challenged Fsp27-deficient mice
por: Zhou, Linkang, et al.
Publicado: (2015)

Therapeutic Intervention with Anti-Complement Component 5 Antibody Does Not Reduce NASH but Does Attenuate Atherosclerosis and MIF Concentrations in Ldlr-/-.Leiden Mice
por: Seidel, Florine, et al.
Publicado: (2022)

FSP27 Promotes Lipid Droplet Clustering and Then Fusion to Regulate Triglyceride Accumulation
por: Jambunathan, Srikarthika, et al.
Publicado: (2011)

CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice
por: Riopel, Matthew, et al.
Publicado: (2018)

The metabonomics study of P-selectin glycoprotein ligand-1 (PSGL-1) deficiency inhibiting the progression of atherosclerosis in LDLR(-/-) mice
por: Li, Binglin, et al.
Publicado: (2018)

PAR4 Inhibition Reduces Coronary Artery Atherosclerosis and Myocardial Fibrosis in SR-B1/LDLR Double Knockout Mice
por: Lee, Samuel K., et al.
Publicado: (2023)

The metabolic conditioning of obesity: A review of the pathogenesis of obesity and the epigenetic pathways that “program” obesity from conception
por: Rajamoorthi, Ananthi, et al.
Publicado: (2022)

The secretome of liver X receptor agonist‐treated early outgrowth cells decreases atherosclerosis in Ldlr−/− mice
por: Rasheed, Adil, et al.
Publicado: (2020)

FSP meeting at Siegen
Publicado: (2017)

A Novel Proangiogenic Function of Fsp27 in Endothelium: You Only Live Thrice?
por: Mineo, Chieko
Publicado: (2019)

Dysregulated CD4(+) T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr(−/−) mice
por: Wilhelm, Ashley J, et al.
Publicado: (2015)

The GLP-1 Analogs Liraglutide and Semaglutide Reduce Atherosclerosis in ApoE(−/−) and LDLr(−/−) Mice by a Mechanism That Includes Inflammatory Pathways
por: Rakipovski, Günaj, et al.
Publicado: (2018)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

The Cordyceps militaris-Derived Polysaccharide CM1 Alleviates Atherosclerosis in LDLR((-/-)) Mice by Improving Hyperlipidemia
por: Yin, Fan, et al.
Publicado: (2021)

Bitter Melon Reduces Head and Neck Squamous Cell Carcinoma Growth by Targeting c-Met Signaling
por: Rajamoorthi, Ananthi, et al.
Publicado: (2013)

Perilipin1 promotes unilocular lipid droplet formation through the activation of Fsp27 in adipocytes
por: Sun, Zhiqi, et al.
Publicado: (2013)

Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr (−/−) Mice Compared to Nondiabetic LDLr (−/−) Mice
por: Engelbertsen, Daniel, et al.
Publicado: (2012)

The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice
por: Hoeke, Geerte, et al.
Publicado: (2017)

Fsp27 promotes lipid droplet growth by lipid exchange and transfer at lipid droplet contact sites
por: Gong, Jingyi, et al.
Publicado: (2011)

Molecular characterization of AIFM2/FSP1 inhibition by iFSP1-like molecules
por: Xavier da Silva, Thamara Nishida, et al.
Publicado: (2023)

Acute lymphoblastic leukemia necessitates GSH-dependent ferroptosis defenses to overcome FSP1-epigenetic silencing
por: Pontel, Lucas B., et al.
Publicado: (2022)

Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
por: Ma, Shizhan, et al.
Publicado: (2019)

Deficiency of Invariant Natural Killer T Cells Does Not Protect Against Obesity but Exacerbates Atherosclerosis in Ldlr(−/−) Mice
por: Subramanian, Savitha, et al.
Publicado: (2018)

Targeted Disruption of LDLR Causes Hypercholesterolemia and Atherosclerosis in Yucatan Miniature Pigs
por: Davis, Bryan T., et al.
Publicado: (2014)

Comparison between genetic and pharmaceutical disruption of Ldlr expression for the development of atherosclerosis
por: Gomes, Diego, et al.
Publicado: (2022)

Up-Regulation of Mitochondrial Activity and Acquirement of Brown Adipose Tissue-Like Property in the White Adipose Tissue of Fsp27 Deficient Mice
por: Toh, Shen Yon, et al.
Publicado: (2008)

Corrigendum: Perilipin1 promotes unilocular lipid droplet formation through the activation of Fsp27 in adipocytes
por: Sun, Zhiqi, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jg1273o7thcrv1761ibd67trgd